Statistics for Corvus Pharmaceuticals (id:6939 CRVS)

Valuation metrics

Market cap

575.10M

Enterprise value

508.28M

Trailing P/E (ttm)

-16.18

Forward P/E

-18.65

PEG ratio

-18.65

Price/Sales (ttm)

Price/Book (mrq)

11.34

Enterprise Value/Revenue

Enterprise Value/EBITDA

-21.84

Overview

Shares outstanding

64.26M

Float

38.00M

Shares short

2.93M

% Held by insiders

0.04%

% Held by institutions

0.44%

Average volume (10 days)

1.01M

Average volume (90 days)

Price summary

52-Week low

1.30

52-Week high

10.00

52-Week change

83.33%

Beta

1.04

50-Day moving average

7.14

200-Day moving average

3.56

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-23.83%

Return on equity

-44.91%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-23,275,000.00

Net income to common (ttm)

-22,616,000.00

Diluted EPS (ttm)

-0.99

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

47.25M

Total cash per share (mrq)

0.76

Total debt (mrq)

700.00K

Total Debt/Equity (mrq)

1.37

Current ratio (mrq)

361.90%

Book value per share (mrq)

0.79

Cash flow

Cash flow statement

-21,239,000.00

Levered free cash flow (LFCF)

-5,976,625.00